Premium Information is available for this item - Upgrade for $1 a day

6505-00-765-1728

Usp Methyclothiazide Tablets

6505007651728 007651728 ENDRUON TABLETS NDC00904-2693-60 4192 NDC00074-6812-01 6812-01

INC: 34895 Methyclothiazide Tablets

6505-00-765-1728 METHYCLOTHIAZIDE TABLETS,USP 6505007651728 007651728

Managed by United States
NSN Created on 1 Jan 1960
Data Last Changed
January 2023
NATO Update Count
6
NATO Data Quality
6505-00-765-1728 METHYCLOTHIAZIDE TABLETS,USP 6505007651728 007651728 1/1
NSN 6505-00-765-1728 (Generic Image) 1/1

6505-00-765-1728 Stock and Availability Marketplace 6505-00-765-1728

6505-00-765-1728 Related Documents Related Documents 6505-00-765-1728 5+ Documents (More...)

ENDRUON TABLETS NDC00904-2693-60 4192 NDC00074-6812-01 6812-01 Managed by United States NSN Created
) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-765-1728 Usp Methyclothiazide Tablets 6505007651728
Usp Methyclothiazide Tablets 6505007651728 Tablets 6505007651728 Tablets 6505011467590 Tablets
Usp Methyclothiazide Tablets 6505012244797 Usp Methyclothiazide Tablets 6505011467590 Tablets 6505007651728
Usp Methyclothiazide Tablets 6505007651728 Tablets 6505011467590 /fsg-65/fsc-6505/us 6505-00-765
-6505 /us 6505-01-146-7590 Usp Methyclothiazide Tablets 6505011467590 Methyclothiazide Tablets 6505007651728
5393 Tablets 6505011885393 https Cognizance:9L NATO Stock Numbers Related to 6505-01-146-7590 6505-00-765-1728
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-188-5393 Usp Methyclothiazide Tablets 6505011885393 6505-00-765-1728
Usp Methyclothiazide Tablets 6505007651728 Methyclothiazide Tablets 6505011467590 Tablets 6505007651728
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-188-5393 Usp Methyclothiazide Tablets 6505011885393 6505-00-765-1728
6505011467590 6505012244797 https//www.nsnlookup.com Methyclothiazide Tablets 6505011885393 6505-00-765-1728
01-146-7590 6505-01-188-5393 https 6505012244797 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-765-1728

6505-00-765-1728 Demil Restrictions 6505-00-765-1728

DEMIL: A | DEMILI: 1 | CRITICALITY: X | HMIC: P | PMIC: A | EDC: | ADPEC:

6505-00-765-1728 is a Usp Methyclothiazide Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.

6505-00-765-1728 HTS and ScheduleB Import and Export 6505-00-765-1728

6505-00-765-1728 End Users End Users 6505-00-765-1728

MOE Rule:
V542
Effective Date:
1 Apr 1991
United States of America (ZZ)

6505-00-765-1728 Manufacturers Approved Sources 6505-00-765-1728

6505-00-765-1728 Technical Data Datasheet 6505-00-765-1728

Characteristic
Specifications
FIIG
A510N0
Active Medicament Medicinal Strength [AKJA]
5.000 Milligrams Methyclothiazide Active Ingredient
Primary Container Type [CQCT]
Bottle
Primary Container Content Quantity [CRLK]
100.000 Tablets
Special Features [FEAT]
Administration:Oral Nonchewable;

6505-00-765-1728 Management Data Management Data 6505-00-765-1728

Effective Date
Organization
Unit of Issue
Unit Price
Qty Unit Pack
Oct 1991
Veterans Administration (VA)
BT
Subscribe
MOE
USC
Code
Statement
Order of Use
Jump To Code
Qty Per Assy
UOM
Technical Document
Quantative Expression
Veterans Administration (VA)
V
K
U/I Contains 100 Tt
00000000100TT

6505-00-765-1728 Similar Items Similar Supply Items to 6505-00-765-1728

6505-00-765-1728 Freight Data Freight Information 6505-00-765-1728

6505-00-765-1728 has freight characteristics.. 6505-00-765-1728 has a variance between NMFC and UFC when transported by rail and the description should be consulted.